Your browser doesn't support javascript.
loading
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention.
Marston, Nicholas A; Pirruccello, James P; Melloni, Giorgio E M; Koyama, Satoshi; Kamanu, Frederick K; Weng, Lu-Chen; Roselli, Carolina; Kamatani, Yoichiro; Komuro, Issei; Aragam, Krishna G; Butterworth, Adam S; Ito, Kaoru; Lubitz, Steve A; Ellinor, Patrick T; Sabatine, Marc S; Ruff, Christian T.
Afiliación
  • Marston NA; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Pirruccello JP; Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Melloni GEM; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Koyama S; Division of Cardiology, University of California San Francisco, San Francisco.
  • Kamanu FK; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Weng LC; Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Roselli C; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Kamatani Y; Laboratory for Cardiovascular Genomics and Informatics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Komuro I; TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Aragam KG; Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Butterworth AS; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ito K; Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Lubitz SA; Laboratory of Complex Trait Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Ellinor PT; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Sabatine MS; Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Ruff CT; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
JAMA Cardiol ; 8(2): 130-137, 2023 02 01.
Article en En | MEDLINE | ID: mdl-36576811
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Aterosclerosis / Infarto del Miocardio Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Cardiol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Aterosclerosis / Infarto del Miocardio Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Cardiol Año: 2023 Tipo del documento: Article